Skip to search formSkip to main contentSkip to account menu

oxaliplatin 100 MG Injection

Known as: OXALIPLATIN 100 mg in 20 mL INTRAVENOUS POWDER, FOR SOLUTION, oxaliplatin 5 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, OXALIPLATIN 100 mg in 20 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION 
National Institutes of Health

Related topics

Related topics

3 relations
InjectionLactose Monohydrateoxaliplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Induction oxaliplatin capecitabine followed by switch to carboplatin-paclitaxel based RT versus continuing oxaliplatin capecitabine RT in operable esophageal adenocarcinoma: Survival analysis of the…
373Background: Initial results of the NEOSCOPE trial comparing pre-operative CarPac vs OxCap based chemoradiotherapy (CRT) in… 
Review
2011
Review
2011
Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
This paper presents a summary of the evidence review group (ERG) report into trastuzumab for the treatment of human epidermal… 
Review
2010
Review
2010
Multimodale Therapie des kolorektalen Karzinoms
ZusammenfassungDie heutige Behandlung kolorektaler Karzinome erfordert die intensive Zusammenarbeit von Chirurgen… 
2010
2010
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin
The primary objective of this study was to determine the activity and safety profile of biweekly oxaliplatin combined with… 
2010
2010
Therapeutic effectiveness of slow-release PLGA-oxaliplatin microsphere on human colorectal tumor-bearing mice
The aim was to develop a slow-release poly-lactic-co-glycolic acid (PLGA)-oxaliplatin microsphere and to assess the therapeutic… 
2009
2009
Cytotoxic, antioxidant activities and structure activity relationship of some newly synthesized terpenoidal oxaliplatin analogs.
2008
2008
Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long…
BACKGROUND In 2003 Wein et al. published data after a short median follow up (23 months). Here we report on the long-term results… 
2008
2008
Biweekly oxaliplatin and irinotecan chemotherapy in advanced gastric cancer. A first-line multicenter phase II trial of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT).
BACKGROUND The aim of the study was to evaluate the feasibility and efficacy of an outpatient oxaliplatin/irinotecan chemotherapy… 
2006
2006
Jüngste Fortschritte in der Therapie des Kolonkarzinoms
ZusammenfassungHintergrund:In der Therapie des kolorektalen Karzinoms wurden in den letzten Jahren bedeutende Fortschritte… 
2001
2001
Neue Therapieoptionen in der Chemotherapie des fortgeschrittenen kolorektalen Karzinoms
ZusammenfassungHintergrund: Die Therapiemöglichkeiten des fortgeschrittenen kolorektalen Karzinoms haben sich in den letzten… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)